AFAP1L1 and adrenal cortex carcinoma: Based on AFAP1L1 mRNA expression level, the survival curves for overall survival (OS) manifested that high expression of AFAP1L1 resulted in worse OS in LGG and STAD patients (Fig. 2B), and the survival curves for disease-free survival (RFS) demonstrated that high expression of AFAP1L1 led to worse RFS in ACC, COAD, and LGG patients (Fig. 2C).